Welcome to our dedicated page for Emerson Elec Co SEC filings (Ticker: EMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Emerson Electric Co. filings document regulatory disclosures for an industrial automation company with NYSE-listed common stock and publicly listed notes due 2029, 2031 and 2037. Recent 8-K filings furnish quarterly results press releases, non-GAAP financial measure commentary, forward-looking statements, segment reporting updates, and material financing arrangements such as credit facility support for general corporate purposes and commercial paper liquidity.
Proxy and governance filings cover annual meeting vote results, director elections, auditor ratification, executive compensation, equity-based awards, and amendments submitted to shareholders. The filing record also documents Emerson's automation-focused reporting structure, including Control Systems & Software and Test & Measurement disclosures tied to industrial AI, control systems, asset optimization software, intelligent test platforms, modular hardware, and related software.
Emerson Electric (EMR) reported an insider equity award. Senior Vice President, Secretary & Chief Legal Officer Michael Tang acquired 7,149 restricted stock units on 11/03/2025, coded “A” under Rule 16b-3(d) as a grant from a shareholder‑approved plan.
Following this grant, Tang beneficially owns 37,196 shares (direct). The RSU grant carries no purchase price per the filing notes.
Emerson Electric Co. furnished a press release announcing its fourth-quarter and full-year results and outlined the use of certain non-GAAP measures. The company cautioned that forward-looking statements are subject to risks described in its most recent Annual Report and subsequent SEC filings.
Separately, the Board authorized the repurchase of up to 50 million shares of common stock over the next several years. This authorization is in addition to the 60 million share program approved in March 2020, which has approximately 20 million shares remaining. Repurchases may occur in open market or private transactions at management’s discretion, may be suspended at any time, and repurchased shares may be used for employee benefit plans and other corporate purposes.
Emerson Electric (EMR) received a Form 25 filing from the New York Stock Exchange to remove its 1.250% Notes due 2025 from listing and/or registration under Section 12(b) of the Exchange Act.
The NYSE certifies compliance with its rules to strike the class from listing, and the filing notes issuer compliance with Exchange rules and 17 CFR 240.12d2-2 provisions governing voluntary withdrawal.
Emerson Electric (EMR) Q3-25 10-Q highlights:
- Net sales rose 4% YoY to $4.55 bn; underlying growth +3% (price +2.5 ppts, volume +0.5 ppt).
- Diluted EPS from continuing ops surged 72% to $1.03, aided by the absence of last year’s $0.38 Copeland note loss; adjusted EPS up 6% to $1.52.
- Segment mix: Intelligent Devices sales +4% (margin 22.5%), Software & Control +3% (margin 16.7%); Test & Measurement loss narrowed sharply ($-26 m vs $-88 m).
- YTD (9 mo) sales +2% to $13.16 bn; diluted EPS $2.91 vs $1.84. Gross margin improved 260 bp to 53.2% on lower purchase-accounting amortization and pricing.
- AspenTech consolidation: on 12 Mar 25 EMR bought remaining AspenTech shares for ~$7.2 bn; AspenTech now in Control Systems & Software. Deal drove $7.2 bn equity reduction, $1.5 bn new long-term notes and $5.4 bn commercial paper.
- Balance sheet shifts: Cash fell to $2.2 bn (-$1.4 bn YTD); short-term borrowings jumped to $6.0 bn; net debt/EBITDA pro-forma ~2.6×. Equity down to $19.9 bn from $27.5 bn as NCI largely eliminated.
- Operating cash flow modestly lower at $2.09 bn (-7% YoY); capex $263 m; financing outflow $3.0 bn (buybacks, dividends, AspenTech purchase).
- Backlog stands at $8.9 bn; 75% expected to convert within 12 months.
- Effective tax rate Q3 21% (up 200 bp) and YTD 25% (up 500 bp) due to AspenTech-related discrete items.
Key takeaways: Emerson delivered solid topline and adjusted profit growth while integrating AspenTech, but leverage, lower cash and higher taxes temper the near-term outlook.